Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD.

Int J Chron Obstruct Pulmon Dis · 2017 · PMC5644571 · PMID 29066880

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

For the other four selective beta-blockers (acebutolol, atenolol, bisoprolol, and metoprolol), lower risks of exacerbation were observed (ORs ranging from 0.85 to 0.97), although they did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.